Effect of oral immunotherapy of nuts in the treatment of type 1 allergy

Not Applicable

• Conditions: Type 1 allergy with food.; Dermatitis due to ingested food; L27.2

• Registration Number: IRCT20240121060754N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients with type 1 allergy after eating nuts

Exclusion Criteria

Patients with cardiovascular diseases, diabetes
Patients with skin symptoms of chronic eczema or active allergic diseases such as asthma, allergic rhinitis and uncontrolled active atopic dermatitis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Allergy symptoms. Timepoint: first visit - 4 to 6 months after treatment. Method of measurement: Questionnaire and visit.;CRD test (Component-resolved diagnosis). Timepoint: first visit - 4 to 6 months after treatment. Method of measurement: Questionnaire and visit.;Skin prick test. Timepoint: first visit - 4 to 6 months after treatment. Method of measurement: Questionnaire and visit.;Specific antibody test (sIegE). Timepoint: first visit - 4 to 6 months after treatment. Method of measurement: Questionnaire and visit.;Total IgE. Timepoint: first visit - 4 to 6 months after treatment. Method of measurement: blood test.